168 related articles for article (PubMed ID: 25745604)
1. The cervix cancer research network: increasing access to cancer clinical trials in low- and middle-income countries.
Suneja G; Bacon M; Small W; Ryu SY; Kitchener HC; Gaffney DK
Front Oncol; 2015; 5():14. PubMed ID: 25745604
[TBL] [Abstract][Full Text] [Related]
2. Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale.
Gaffney D; Small B; Kitchener H; Young Ryu S; Viswanathan A; Trimble T; Covens A; Wilailak S; Lertkhachonsuk AA; Sitathanee C; Mahantshetty U; Fisher B; Springer S; Pollatz T; Spiller A; Bacon M; Jhingran A
Int J Gynecol Cancer; 2016 Nov; 26(9):1690-1693. PubMed ID: 27779548
[TBL] [Abstract][Full Text] [Related]
3. Advancing clinical research globally: Cervical cancer research network from Mexico.
Ager BJ; Gallardo-Rincón D; de León DC; Chávez-Blanco A; Chuang L; Dueñas-González A; Gómez-García E; Jerez R; Jhingran A; McCormack M; Mileshkin L; Pérez-Plasencia C; Plante M; Poveda A; Gaffney DK
Gynecol Oncol Rep; 2018 Aug; 25():90-93. PubMed ID: 30014021
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. A Family-Centered Sexual Health Intervention to Promote Cervical Cancer Screening Uptake Among Low-Income Rural Women in India: Protocol for a Community-Based Mixed Methods Pilot Study.
Vahabi M; Lofters AK; Mishra G; Pimple S; Wong JP
JMIR Res Protoc; 2022 Sep; 11(9):e35093. PubMed ID: 36074549
[TBL] [Abstract][Full Text] [Related]
7. Interventions targeted at women to encourage the uptake of cervical screening.
Staley H; Shiraz A; Shreeve N; Bryant A; Martin-Hirsch PP; Gajjar K
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD002834. PubMed ID: 34694000
[TBL] [Abstract][Full Text] [Related]
8. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
9. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
10. Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Patient Accrual in Puerto Rico.
Kunos CA; Massett HA; Galassi A; Walker JL; Good MJ; Díaz LB; McCaskill-Stevens W
Front Oncol; 2018; 8():102. PubMed ID: 29692980
[TBL] [Abstract][Full Text] [Related]
11. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
12. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
[TBL] [Abstract][Full Text] [Related]
13. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
[TBL] [Abstract][Full Text] [Related]
14. The development of priority cervical cancer trials: a Gynecologic Cancer InterGroup report.
Kitchener HC; Hoskins W; Small W; Thomas GM; Trimble EL;
Int J Gynecol Cancer; 2010 Aug; 20(6):1092-100. PubMed ID: 20683424
[TBL] [Abstract][Full Text] [Related]
15. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Tata Memorial Centre, India, to cervical cancer care: Journey of two decades.
Kumar A; Chopra S; Gupta S
Indian J Med Res; 2021 Aug; 154(2):319-328. PubMed ID: 35295006
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of cancer of the cervix: global and national perspective.
Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K
J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Cervix Cancer in India.
Mishra GA; Pimple SA; Shastri SS
Oncology; 2016; 91 Suppl 1():1-7. PubMed ID: 27463969
[TBL] [Abstract][Full Text] [Related]
19. An updated assessment of 43,110 patients enrolled in the Childhood Cancer Research Network: A Children's Oncology Group report.
Brown AL; Sok P; Scheurer ME; Rabin KR; Marcotte EL; Hawkins DS; Spector LG; Lupo PJ
Cancer; 2022 Jul; 128(14):2760-2767. PubMed ID: 35482017
[TBL] [Abstract][Full Text] [Related]
20. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
